We have seen a lot of spreadsheets, PDFs, documents, and more in our many Rhazdrugs builds. One thing we’ve learned that is universal is you can have the very best policies and hazardous drug handling information, but if it isn’t easy to access and easy to understand, who is it serving? Your hazardous drug handling information is about more than USP <800> compliance; you’re protecting your employees.

Our conversations with customers and prospects consistently reveal crucial information about the challenges in protecting healthcare workers from hazardous drug exposure. A recent discussion with a major healthcare system, with over 17,000 employees and 3,000 affiliated physicians, highlighted their impressive proactive approach to safety.

Rhazdrugs’ most significant and beneficial feature is its ability to integrate directly into an Electronic Health Record (EHR). Our product metrics show that nurses and clinicians are nearly twice as likely to access vital hazardous drug safety information when it is accessible directly from the EHR compared to when it is not. This can be critical in patient outcomes and healthcare worker safety.

Welcome to the Rpharmy School of Hard Knocks, where we wholeheartedly believe that embracing the successes and challenges of others enhances our learning! 

At Rpharmy, our solutions are deployed across hundreds of hospitals. Through our collaborative relationships with these institutions, we have gained deep insights into their challenges and wins. These five lessons learned during the USP <800> compliance process have percolated to the top through these relationships. We hope these insights help as you continue the critical work of protecting healthcare workers from the dangerous effects of hazardous drug exposure.

Medication Safety Solution Provider Significantly Upgrades Only Comprehensive Online Database of Medication Boxed Warnings

A few weeks ago, we wrote about our quest to improve the user experience across our software. Now we’re back to let you know that our new and improved BlackboxRX is live! 

Our #1 highest priority is improving patient outcomes and the health and well-being of healthcare workers. We accomplish this by making your critical job easier through easy-to-use but in-depth safety information platforms. We never see our job as complete in this area and are always working for you. 

In the last few years, we’ve focused on ensuring our products meet your USP <800> compliance and medication safety needs by ramping up the drug monograph and safety information. More recently, we recognized a need to improve the user experience (UX) of our solutions, enhancing the look, feel, and functionality of our products. We embarked on an extensive UX project with Ix (pronounced Nine), a talented user experience designer. From seemingly minor customer requests to our latest UX endeavor, it’s all for you!

Formulary Management, Hazardous Drugs Safety Information SaaS Provider Joins Group Purchasing Organization to Help Improve Patient, Healthcare Worker Safety

We are thrilled to announce that Rpharmy has been awarded a national group purchasing agreement for Drug Information and Surveillance Solutions with Premier Inc., a group purchasing organization, in a shared mission to enhance patient and healthcare worker safety through the use of Rhazdrugs and Formweb. This partnership underscores our collective commitment to improving healthcare outcomes.

Every hospital or healthcare facility is distinctive in two critical ways concerning hazardous drugs: their unique hazardous drugs list and how they communicate the safety information related to those drugs. Of course, there are regulations and requirements like USP <800> and NIOSH lists, etc., that dictate aspects of the list or the communication requirements, but outside of those standards, organizations have room to customize for their needs. 

One of those unique needs is to identify and communicate safety protocols to protect healthcare workers from unintentional occupational exposure to “illicit drugs” or what other organizations refer to as “street drugs.”